Seminars in Nephrology, Vol 41, No 2, March 2021, pp 168−179 Authors: Al Jurdi A, Da Silva Martins J, Riella LV Download article here: Mineral bone disorders in kidney transp…
Am J Kidney Dis. 2021 Mar 24:S0272-6386(21)00501-1. doi: 10.1053/j.ajkd.2021.01.015. Authors: Sprangers B, Riella LV, Dierickx D. Abstract: Post-transplant lymphoproliferative disorder (PTLD) is one of the most feared complications following kidney…
Front Med. 2020 Jul 21;7:423. Authors Benedetti C, Waldman M, Zaza G, Riella LV, Cravedi P. Abstract The new coronavirus disease 2019 (COVID-19) has become a world health emergency. The disease…
Front. Immunol. 2020 Aug 7;11:1748. Authors Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV Abstract Elderly individuals are the most susceptible to an aggressive form of coronavirus disease (COVID-19),…
KIDNEY360 1: 130–140, 2020. Shruti Gupta , Frank B. Cortazar, Leonardo V. Riella, and David E. Leaf Full PDF version on this link Abstract Immune checkpoint inhibitors (ICPIs) have transformed…
Chong AS, Rothstein DM, Safa K, Riella LV. Minireview on Outstanding Questions in Transplantation: B Cells, Alloantibodies, and Humoral Rejection. Am J Transplant. 2019 Feb 25. doi: 10.1111/ajt.15323. Abstract Over…
Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Authors Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD. Abstract In kidney transplant recipients,…
Belatacept in kidney transplantation - past and future perspectives. Authors: Siddiqui Z, Tedesco-Silva H, Riella LV. Abstract Calcineurin inhibitors (CNIs) are used widely for maintenance immunosuppression in renal transplant recipients.…